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ABSTRACT 
Proteins are susceptible to oxidation by reactive oxygen species, where the type of 
damage induced is characteristic of the denaturing species.  The induction of protein carbonyls is 
a widely applied biomarker, arising from primary oxidative insult. However, when applied to 
complex biological and pathological conditions it can be subject to interference from lipid, 
carbohydrate and DNA oxidation products. 
More recently, interest has focused on the analysis of specific protein bound oxidised 
amino acids.  Of the 22 amino acids, aromatic and sulphydryl containing residues have been 
regarded as being particularly susceptible to oxidative modification, with L-DOPA from tyrosine, 
ortho-tyrosine from phenylalanine; sulphoxides and disulphides from methionine and cysteine 
respectively; and kynurenines from tryptophan. Latterly, the identification of valine and leucine 
hydroxides, reduced from hydroperoxide intermediates, has been described and applied. 
In order to examine the nature of oxidative damage and protective efficacy of antioxidants 
the markers must be thoroughly evaluated for dosimetry in vitro following damage by specific 
radical species. Antioxidant protection against formation of the biomarker should be 
demonstrated in vitro. Quantification of biomarkers in proteins from normal subjects should be 
within the limits of detection of any analytical procedure.  Further to this, the techniques for 
isolation and hydrolysis of specific proteins should demonstrate that in vitro oxidation is 
minimised.  There is a need for the development of standards for quality assurance material to 
standardise procedures between laboratories.  
At present, antioxidant effects on protein oxidation in vivo are limited, and include animal 
studies, where dietary antioxidants have been reported to reduce dityrosine formation during rat 
exercise training. Two studies on humans have been reported this year. The further application of 
these methods to human studies is indicated, where the quality of the determinations will be 
enhanced through inter-laboratory validation. 
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INTRODUCTION 
Proteins constitute more than 50% of the dry weight of cells, and as such can be 
considered important targets for the effects of oxidising species. The rate of reaction of amino 
acids with radiolytically generated •OH, is of the same order of magnitude as PUFA and DNA 
bases [1], indicating that proximity to site of oxidant generation and the presence of bound metal 
ions are the major determinants of intracellular targets for oxidation. 
The earliest work on the oxidation of a biologically important protein was on the effects 
of selected radicals generated by radiolysis on the enzyme, lysozyme [2]. Both the thiocyanate 
radical (a selective modifier of tryptophan) and •OH were found to inactivate the enzyme, 
implying that tryptophan residues are essential for biological activity, now well established from 
classical enzymology. Similarly, for α-1-antitrypsin, it was found that modification of a single 
methionine residue at position 358 rendered the protein inactive [3]. Subsequent hydrolysis and 
amino acid analysis revealed the presence of methionine sulphoxide. This was one of the first 
pieces of evidence linking amino acid oxidation to denaturation of proteins and loss of function.  
The process of protein oxidation frequently introduces new functional groups, such as 
hydroxyls and carbonyl, which contribute to altered function and turnover. Improved 
characterisation of the effects of protein oxidation has identified a spectrum of secondary effects 
including fragmentation, crosslinking and unfolding, which may accelerate or hinder proteolytic 
and proteasome-mediated turnover, according to the severity of oxidative damage [4]. 
The effects of reactive oxygen species are not always deleterious; collagenase can be 
released from its latent form following oxidation by hypochlorous acid, and also by a metal ion 
dependent product of O2-. [5,6]. Furthermore, the DNA binding of the transcription factor, AP-1, 
is modulated via intracellular redox status; the reduction of a single cystine in the DNA binding 
domain is necessary for the binding of the AP-1 heterodimer [7]. Many modified amino acids 
have the capacity to exert distant effects, away from the initial site of oxidative attack, and as 
such, are likely to play an important role in signal transduction processes. The differential 
induction of MAP-kinases elicited in epithelial cells by peroxynitrite is associated with 
nitrotyrosine formation, where selenium supplementation attenuated both formation of the 
nitrated protein and signalling [8]. 
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As the role of ROS as intracellular signalling molecules becomes further elucidated, the 
importance of oxidised protein moieties as effectors of these pathways can be characterised. The 
stability of certain oxidised proteins may convey memory in the cells of previous oxidative 
attack, thereby facilitating a more rapid response to further oxidative insult. From our increasing 
power to resolve and characterise oxidised proteins, in association with significant advances in 
cell biology the importance of protein oxidation will begin to be realised. 
 
PROTEIN OXIDATION IN PATHOLOGY 
Within the literature, there are many published reports of the presence of elevated protein 
oxidation products in the “ageing-related” diseases. These include; (1) cataractogenesis, where 
the opacity of the lens may be due to UV oxidised tryptophan residue accumulation within lens 
crystallin proteins[9]. These proteins are removed by reticulocytic processes and proteosomes;  
(2) Atherosclerosis, where oxidation of the apolipoprotein B moiety on LDL alters receptor 
recognition[10]. The resultant non-regulated path of LDL uptake is implicated in foam cell 
formation;  
(3) Diabetes, where elevated plasma glucose levels are believed to contribute to protein bound 
glucose derived oxidising species[11]. These may be important in basement membrane damage to 
proteins such as collagen, thereby contributing to diabetic complications;  
(4) Rheumatoid arthritis, where oxidative modification to IgG has been suggested to lead to a 
self-perpetuating inflammatory lesion within the affected joint[12]; and  
(5) Neurodegenerative diseases, such as Alzheimer’s disease, where altered amyloid precursor 
protein processing result in a peptide capable of generating oxidants, and elevated levels of 
oxidised protein are reported[13]. 
 Each pathology differs in both the source of oxidising species and the target protein, 
indicating the random nature of radical attack, governed only by protein size and concentration in 
the local region of oxidative stress.  
 An observable increase in reported levels of biomarkers of protein oxidation may arise 
from either enhanced oxidative stress and/or decreased antioxidant status. Many studies have 
undertaken analysis of antioxidant capacity in disease. These are summarised in Table 1.  This 
evidence lends credence to the hypothesis that antioxidant insufficiency may accelerate the onset 
ageing-related diseases. Whilst clinical and epidemiological studies have indicated that 
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antioxidant nutrients may be effective in disease management, the analysis of their capacity to 
reduce in vivo oxidative damage has barely been touched  [14]. The establishment of appropriate 
biomarkers of protein oxidation will aid analysis of antioxidant efficacy in vivo. 
 
BIOLOGICAL SOURCES OF OXIDANT STRESS RELEVANT TO PROTEIN OXIDATION 
 The superoxide anion radical is considered the primary oxygen radical species formed 
from a single electron reduction of molecular oxygen. In physiological and pathophysiological 
systems it can be generated from a variety of different sources. The energy emitted by UV light is 
insufficient to cause photolysis of water. Rather UV mediates its oxidative damage through direct 
excitation of susceptible amino acids, such as tryptophan, in the presence of molecular oxygen. 
Subsequent charge transfer to dissolved oxygen in the aqueous environment results in elevated 
H2O2 concentrations in the immediate environment of the protein. 
 The mitochondrial respiratory chain carries pairs of reducing equivalents to molecular 
oxygen, however, leakage of single electrons occurs, which is accentuated during physiological 
stress and increases during ageing [33]. Mitochondria are implicated in generation of oxidative 
stress within ageing neurones [34]. 
 The initial bactericidal defence launched against foreign material and invading pathogens 
is the respiratory burst. First identified in polymorphs but now widely reported in other cell types, 
a membrane bound NADPH oxidase catalyses the production of O2-. from molecular oxygen, at 
the expense of NADPH. Azurophilic granules within PMNs, enriched in myeloperoxidase, 
catalyse the formation of hypochlorous acid from hydrogen peroxide and chloride. Eosinophils 
generate a related hypohalous acid from bromide [35]. PMNLs may generate up to 100µmol 
H2O2 per minute at an inflammatory site, and have been implicated in both the pathophysiology 
of rheumatoid arthritis and atherosclerosis[10,12].  Whilst these species are not radicals per se, 
they are oxidising species, whose biological effects can be limited by antioxidants and are 
therefore worthy of study.  
 Protein bound glucose can undergo autoxidative glycosylation, whereby the autoxidation 
of sugar via dicarbonyl residues generates superoxide radicals adjacent to the protein backbone. 
Free sugars may also undergo autoxidation in the presence of catalytic metal ions. Elevated 
plasma concentrations of glucose in diabetes are believed to contribute to enhanced oxidative 
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stress through these processes although the relative importance of the two pathways remains to be 
elucidated [11]. 
 The production of nitric oxide (NO) by endothelial and neuronal cells is determined by 
the activity of distinct isoforms of nitric oxide synthase. The effects of NO in the nervous system 
and within the vasculature are attenuated by O2- . The product of this interaction, peroxynitrite, is 
a potent oxidising species [36].  
Biologically important transition metal ions such as copper and iron redox cycle in the 
presence of superoxide anion and H2O2 to generate the short lived highly reactive hydroxyl 
radical through Fenton Chemistry. The spectrum of oxidised products formed from •OH damage 
is broad, and encompasses both aromatic and aliphatic amino acid modifications [4].  
 
CHEMISTRY OF AMINO ACID OXIDATION 
Generally, those amino acids capable of delocalising charge are more susceptible to 
oxidant attack, such as amino acids containing aromatic and sulphur side chains. However, 
carbonyls are ubiquitous products of oxidation arising from many amino acids in addition to 
sugars and lipids [37]. Both oxo-acids and aldehydes are formed following oxidative attack, 
having either the same number or one carbon atom less than the original amino acid [38]. 
Any study of the formation of carbonyls in a physiological system cannot differentiate 
between those formed through addition of other oxidised products (e.g. glucose, malondialdehyde 
[39]) and protein oxidation itself, and thus should be considered as a broad marker of oxidation 
[37]. Cao and Cutler have extensively investigated the determination of protein carbonyls in 
tissue, and conclude that the method of DNPH derivatisation is valid only for the study of 
purified proteins [40]. 
In contrast, formation of hydroperoxides and hydroxides by the addition of hydroxyl 
radical in the presence of oxygen, across the side chains of amino acids is relatively specific to 
aliphatic amino acid side chains. Extensive characterisation of the three isomeric forms of valine 
and leucine hydroxides has been undertaken by Fu et al [41,42]. 
The postulated reactions mediating formation of protein (Pr) hydroperoxides and 
hydroxides following •OH attack are shown in equations 1-6. 
1. PrH + •OH              Pr• + H2O 
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2. Pr• + O2                 PrOO• 
3. PrOO• + e-              PrOO- 
4. PrOO- + H+           PrOOH  (hydroperoxide) 
5. PrOOH + RH        PrO• + H2 O + R• with possibility of further reaction 
6. PrO• + RH            PrOH (hydroxide) + R• with possibility of further reaction 
 
Histidine is frequently involved in the co-ordination of metal ions, and thus is a target for 
metal catalysed oxidation [38]. Generation of 2-oxohistidine is observed during in vitro LDL 
oxidation, which is inhibitable by vitamin C [43]. 
The free thiol group of cysteine readily undergoes reversible oxidation to form a 
disulphide, which can be “repaired “ in the presence of a thiol donor such as glutathione. Further 
oxidation leads to an irreversible oxidation to cysteic acid [44].  
The biological significance of methionine oxidation is exemplified by the existence of a 
specific repair enzyme present in many cell types, methionine sulphoxide reductase. Repair of the 
initial sulphur radical formed by •OH attack, can also be achieved in vitro, through aqueous 
antioxidants. Whilst methionine sulphoxide was one of the first biologically relevant products of 
oxidative attack, there is no simple analytical procedure and hence it has not been widely 
examined. In vitro studies of HDL oxidation have confirmed the early formation of methionine 
sulphoxide, and furthermore, this is protected by alpha-tocopherol [45]. 
 The light energy emitted by UV radiation can be directly absorbed by tryptophan, 
producing an excited intermediate. The radical can be dissipated though transfer to dissolved 
oxygen (to yield O2-.) by antioxidants or through charge transfer; the movement of an unpaired 
electron along a peptide or protein backbone to a susceptible amino acid of lower redox potential.  
Thus, in any given protein, the target of attack may not be the ultimate site of damage. In 
the absence of charge transfer or repair, tryptophan undergoes a ring opening following •OH 
attack to yield predominantly N-formyl kynurenine and kynurenine[46].  
 Tyrosine dimerisation has been proposed to contribute to the aggregation of proteins 
frequently observed on oxidation. However, since oxygen and antioxidants rapidly repair the 
phenoxyl radical intermediate, it is only likely to be a significant product in metalloproteins, 
where the intermediate is stabilised through change in redox status of the associated transition 
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metal [47]. There are a number of reports demonstrating the generation of protein bound L-
DOPA from tyrosine in a dose dependent fashion following •OH attack [48,49]. L-DOPA is a 
relatively long-lived species which can confer reducing activity in its environment.  The 
nucleophilic non-radical oxidant, HOCl, is particularly reactive with tyrosine, inducing the 
characteristic chlorotyrosine. A further ring addition product of tyrosine, nitrotyrosine, is formed 
from attack by nitrating species including nitric oxide, peroxynitrite and reactions between 
hypochlorite and nitrogen containing species [reviewed in 4]. 
Hydroxylation of phenylalanine is a typical reaction of hydroxyl radicals, where the 
resultant tyrosine is hydroxylated at the ortho-, para- or meta- position, and is therefore distinct 
from native tyrosine. 
 It is evident from the body of evidence presented, that a “fingerprint” of the oxidising 
species present in vivo, should be attainable by adopting a broad spectrum of biomarkers.  Several 
groups have undertaken studies examining the prevalence of some of the protein oxidation 
products described above, in disease, and these are summarised in Table 3. 
For an oxidised amino acid to be presented as a marker of biological oxidation in vivo, it 
must meet several criteria. Firstly, the biomarker should be generated in vitro in a dose dependent 
manner following exposure to oxidative stress. In addition, it should be a stable product that is 
not destroyed during sample processing.  
Ideally, the formation of the biomarker should be attenuated in vitro by antioxidants. For 
example, the myoglobin peroxyl radical can be scavenged effectively by ascorbate and vitamin E 
[57].  However, Stadtman and Berlett [58] demonstrated that Fenton chemistry induced amino 
acid oxidation could not be protected by antioxidants, indicating a localised site-specific 
generation of ROS, not available for scavenging by the bulk phase. Recent data from our 
laboratory investigating the protective effects of antioxidants C and E against formation of L-
DOPA and kynurenine induced by metal catalysed oxidation of IgG have shown the effects of 
ascorbate to be dose dependent (unpublished observations). At concentrations of 100µM, both 
antioxidants afforded protection against induction of L-DOPA by metal catalysed oxidation. 
However, a significant induction of L-DOPA occurred in the presence of ascorbic acid (300µM) 
either alone or in the presence of copper and hydrogen peroxide. This suggests that ascorbate is 
behaving as a pro-oxidant. However, ascorbate did not induce formation of kynurenine, nor was 
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any significant protection against kynurenine formation afforded by either vitamin C or E 
between 30 and 300µM. This suggests that either the intermediate(s) in the pathway to the 
formation of kynurenine are “caged” and inaccessible to protective factors, or that the 
intermediates have higher redox potentials than the scavenging species.  
Finally, the biomarker should be detectable in normal plasma within the limits of 
detection of the assay, where the presence of the oxidised product can arise only from non-
enzymatic, oxidative processes. Normally, the measurement of oxidised amino acids within 
protein backbones suffices, as modified amino acids are not incorporated into newly synthesised 
proteins, whereas products such as L-DOPA may arise as freely from enzymatic degradation of 
tyrosine.  
 
EFFECTS OF DIETARY ANTIOXIDANTS ON IN VIVO PROTEIN OXIDATION 
 The use of protein biomarkers as indices of biological protection afforded by dietary 
antioxidants is in its infancy. We have recently completed a study where, for the first time, a 
protective effect against protein oxidation following long term supplementation with 400mg 
vitamin C per day is observed [59]. In a dual phase study, 40 normal subjects initially received 
400mg/day vitamin C for 15 weeks following a 5-week placebo period. This was followed by a 
randomised double blind phase for a further 10 weeks. Immunoglobulin carbonyl content was 
measured at five weekly intervals and vitamin C supplementation was found to significantly 
reduce the degree of oxidation after 10 weeks (p<0.01), with an overall negative correlation 
being observed between IgG carbonyl content and ascorbate concentration (r=-0.1452, 
p=0.0187). However, after five weeks supplementation, no reduction in carbonyl content was 
observed and a positive correlation was observed between ascorbate concentration and IgG 
carbonyl content (p=0.0275). These results are consistent with the hypothesis that dietary 
antioxidants can modulate the extent of plasma protein oxidation. In a smaller study, where 5 
subjects received weekly increasing doses of fruit juice over 4 weeks to investigate quercetin 
antioxidant activity, an increase in plasma levels of 2-amino-adipic semialdehyde was observed 
[60]. However, erythrocyte levels remained unaffected by dietary quercetin in fruit juice over the 
duration of the study. Both of these studies indicate that protein biomarkers are sensitive to 
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antioxidant intervention, where dose and duration of supplementation and protein target may 
yield further information. 
 
NON-ANTIOXIDANT EFFECTS OF ANTIOXIDANTS 
 The dietary vitamin C is well known for its Janus face; behaving on the one hand as an 
antioxidant, and on the other as a pro-oxidant. This has been demonstrated in vitro, where 
ascorbic acid is an effector of oxidative damage, by serving as a reducing agent [61]. Similarly, 
the formation of the alpha-tocopheryl radical has been suggested to contribute to damaged 
proteins within atherosclerotic plaques [53]. The efficacy of an antioxidant in scavenging radical 
intermediates is likely to depend on the absolute concentration of antioxidant at the site of stress 
and the species of radical generated [62]. Such effects can be more closely analysed through the 
evaluation of several biomarkers within different proteins.  
 
CURRENT ANALYTICAL PROCEDURES 
 The methodology applied to the measurement of physiological protein oxidation varies 
from immunodetection by ELISA or Western blot, to analytical HPLC, capillary electrophoresis 
and GC-MS. Several antibodies are available for the detection of nitrated tyrosine and the 
dinitrophenyl hydrazine carbonyl product. These have been recently reviewed by the author [63].  
The measurement of protein carbonyls has traditionally depended on the derivatisation of 
carbonyl groups by dintrophenylhydrazine, with spectrophotometric determination at 360nm of 
the resultant phenylhydrazone. Partial characterisation of the spectrum of oxidised proteins has 
been achieved by gel filtration HPLC of the derivatised product. More recent analyses have 
focused on the use of a monoclonal antibody raised to the hydrazone, with qualitative analysis by 
Western blot [64]. We have developed an ELISA procedure for quantitative analysis of carbonyl 
content on specific proteins, which has identified a protective effect of long term 
supplementation with 400mg vitamin C per day [59,65].  
 The determination of oxidised amino acids within proteins requires an initial hydrolysis 
step, to cleave the proteins of interest. The method of hydrolysis is dependent on the endpoint 
analysis; for example tryptophan and related moieties are destroyed by acid hydrolysis (Table 4).  
The hydrolysis step is an area of concern with regard to the possibility of artefactual 
induction in vitro of oxidised amino acids. Steps should be undertaken to minimise oxidation, 
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such as through the addition of mannitol. In addition, the presence of lipids in plasma samples 
can contribute to significant secondary modification, such that delipidation should be undertaken 
in the early stages of sample preparation.  
 Protein hydroperoxides are degraded by either enzymatic or acid hydrolysis, and can only 
be successfully measured in low MW plasma filtrates, where the quenching effect of larger 
proteins is removed [42]. In addition, they are rapidly broken down in the presence of metal ions 
[66]. Hydroperoxides can be effectively repaired by antioxidants in vitro, which makes them 
attractive potential biomarkers. However, for the reasons stated above it is not possible to detect 
hydroperoxides by chemiluminescence within a quenching environment. Instead, hydroperoxides 
can be effectively reduced to hydroxides post-extraction, which are stable, long-lived 
intermediates in protein oxidation. Subsequent analysis of hydroxides has largely been restricted 
to measurement of leucine, valine and more recently the hydrophilic surface amino acid, lysine 
[41,67]. HPLC analysis requires a two step procedure; initially samples are fractionated on an 
amino column, followed by further chromatography of OPA derivatised products using a Zorbax 
ODS column, with fluorescence detection.   
 Several groups have undertaken the measurement of oxidised tryptophan metabolites over 
the past ten years [52,53]. All have utilised reverse phased chromatography, eluting the oxidised 
residues with increasing acetonitrile concentration. Eluent is monitored with native UV 
absorption and autofluorescence. Peak identity has been confirmed by spiking with authentic 
standard, UV and fluorescence spectra. Elevated levels of N-formyl kynurenine have been 
observed in cataractous lenses, IgG from patients with rheumatoid arthritis and in LDL from 
atherosclerosis patients [52,53,9]. 
 Detection of the oxidised tyrosine moiety, L-DOPA, following HPLC also relies on native 
UV absorption (280nm) and autofluorescence (Ex280nm, Em 320nm). The formation of o and m 
tyrosine from phenylalanine can be observed under the same analytical conditions. In contrast, 
dityrosine is followed using longer wavelength fluorescence emission at 410nm. The debate as to 
the physiological relevance of bityrosine, is set to rage with a number of contradictory reports in 
the literature [13,68]. However, as alluded to in the previous section, the propensity to form bi-
tyrosine is likely to be dependent on the structure of the protein under attack.   
 3-nitrotyrosine can be quantified by ELISA or HPLC using either UV/fluorescence or 
electrochemical detection [69]. The extra-virgin olive oil antioxidant, hydroxytyrosol inhibits in 
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vitro generation of nitrotyrosine by peroxynitrite [70]. However, Whiteman and Halliwell have 
demonstrated the reduction of nitrotyrosine by hypohalous acid, thus questioning the validity of 
nitrotyrosine as a biomarker [71]. This possibility for destruction by other oxidants may account 
for some of the ambiguities existing in the determination of nitrotyrosine in atherosclerotic 
plaques. The significance of tyrosine modification has been extensively reviewed by Crow [72].    
 Based on these criteria, and the observations of unequivocal elevation in disease, 
the likely candidates are isolated protein carbonyls (accepting that these may arise from 
secondary processes), hydroxides, kynurenines, L-DOPA, ortho-tyrosine and chlorotyrosine, 
whilst the validity of nitro-tyrosine has been questioned [71]. 
 
STANDARDISATION 
 There is a significant requirement for standardisation in the many protocols currently 
adopted in different laboratories world-wide. This can be provided through the preparation of a 
quality assurance material containing the native and oxidised amino acids of interest, of at least 
10kDa, which can be isolated by acid precipitation. Such a material could be processed through 
protein extraction procedures and used to confirm minimal in vitro oxidation. In addition, 
different protein hydrolysis methods must be examined, to assess efficiency, yield and potential 
for artefactual induction of oxidised residues. We have demonstrated the stability of protein 
carbonyls on storage for 3 months at –80oC. Furthermore, we and others [44,45,48] have 
confirmed that the protein hydrolysis and extraction procedures used do not induce oxidative 
damage by incorporating tyrosine and tryptophan into hydrolytic procedures. Such validations are 
vital before analysis of large numbers of samples in a supplementation trial, or indeed, in any 
clinical study. There is also a need for appropriate internal standard material, which is not subject 
to oxidative variation. Again, this may be addressed through the quality assurance procedures. 
  
CONCLUSION 
 Analysis of protein oxidation has finally come of age. Together with the advances in 
proteomics, our understanding of the differential susceptibility of proteins to oxidative insult, 
will be further enhanced. This paper has highlighted the advantages of adopting several 
biomarkers for studying in vivo oxidation of proteins and these methods should now be carefully 
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applied using quality assurance material, to controlled studies of antioxidant intake, to evaluate 
the significance of dietary antioxidants in preventing physiological oxidative changes. 
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TABLE 1; Antioxidant status in diseases associated with increased protein oxidation 
Antioxidant Cataractous lenses Atherosclerosis  Diabetes mellitus  Rheumatoid arthritis  Alzheimer’s disease 
Ascorbic acid Mild cataract have 
88µmol/100mg 
tissue compared to 
Advanced cataracts 
– 50µmol/100g [15] 
Reduction in plasma 
vitamin C 
hypertensives with 
elevated LDL 
oxidation [20] 
Reduced plasma 
vitamin C in 
diabetes [reviewed 
in 25]. 
Loss of ascorbate, 
majority of plasma 
ascorbate found as 
dehydroascorbate 
[28] 
Significantly 
reduced in AD brain 
p<0.001 [31] 
Alpha – tocopherol 4.4µmol/kg lens 
tissue compared 
with 33µmol/ml of 
plasma [16]. 
Decrease in red cell 
but not plasma 
vitamin E [21] 
  Significantly 
reduced in AD brain 
p<0.01 [31] 
Glutathione and 
related enzymes 
Reductions in GSH 
and GSH synthetase 
[17,18]. 
 Increase in GSSG 
[18]. 
GSH peroxidase 
reduced to 65% of 
normals. Loss of 
GSH reductase 
activity [22]. 
Significantly lower 
GSH compared to 
controls [26] 
 Pathogenesis 
Catalase No loss of catalase 
[19] 
Reduction in 
neutrophil catalase 
in hyperlipo-
proteinemics [23] 
 Low levels in 
synovial fluid [29] 
 
Superoxide 
dismutase 
Loss of  SOD with 
increasing opacity 
of lens [19]. 
MnSOD reduced to 
25% of control [24] 
CuZn not affected 
SOD increased [27] Low activity in 
synovial fluid and 
plasma [29,30] 
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TABLE 2; Biologically important redox couples.  
Redox couple Eo/V 
RS• H+ / RSH 1.0 
Trp•  H+/ Trp 0.98 
Tyro-• H+ / TyrOH 0.65 
 
 
 
 25
TABLE 3; The presence of potential biomarkers of protein oxidation in disease  
Potential biomarker of protein 
oxidation 
Evidence for accumulation in disease Selected references 
Carbonyls Ageing, Werner’s syndrome 
Diabetes (eye) 
50 
51 
Hydroxides Leucine (2) OH in cataractous lens 
Valine (1) OH and Leucine (2) OH in 
atherosclerotic plaques 
41 
 
48 
N-formyl kynurenine and 
kynurenine 
Rheumatoid arthritis 
LDL from atherosclerosis  
52 
53 
Dityrosine Aged brain 
Atherosclerotic plaque 
13 
48 
L-DOPA Atherosclerotic plaque 
Cataract 
48 
49 
O and M tyrosine Atherosclerotic plaque 48 
Nitro-tyrosine Colon cancer 
Coeliac disease 
54 
55 
Chloro-tyrosine LDL from atherosclerotic intima 56 
 
  
 
 
 
TABLE 4; Hydrolysis of proteins for amino acid analysis 
Hydrolysis Procedure Analyte 
Gas phase hydrolysis; 5% mercaptoacetic acid, 
1% w/v phenol in 6M HCl 
Leucine and valine hydroxide [41] 
Pronase E, 24 hours Tryptophan metabolites [52,53] 
 
